ABTIS
AbTis is a biotechnology company that provides antibody-drug conjugation technology and solubilization.
ABTIS
Industry:
Biotechnology Health Care Medical Device
Founded:
2016-08-01
Address:
Gunpo, Kyonggi-do, South Korea
Country:
South Korea
Website Url:
http://www.abtis.co.kr
Status:
Active
Contact:
82-31-294-0880
Email Addresses:
[email protected]
Technology used in webpage:
Nginx Euro Korea Telecom
Similar Organizations
Kintai Therapeutics
Kintai is a biotechnology company that advancing precision therapeutics based on enteric signaling networks in the human body.
Official Site Inspections
http://www.abtis.co.kr Semrush global rank: 8.59 M Semrush visits lastest month: 284
- Host name: server-3-167-37-3.iad61.r.cloudfront.net
- IP address: 3.167.37.3
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "AbTis"
AbTis - Crunchbase Company Profile & Funding
Organization. AbTis . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email …See details»
AbTis
AbTis is a bio-technology company which is specialized in antibody-drug conjugates (ADC) linker platform with its own proprietary technology. We are developing the 3rd generation of ADCs to …See details»
AbTis
AbTis’ management team consists of highly experienced expertise more than 20 years of pharmaceutical industry in drug discovery and clinical development with international scientific …See details»
AbTis Company Profile 2024: Valuation, Investors, …
AbTis General Information Description. Operator of a biotechnology company intended to offer antibody-drug conjugation technology and solubilization of …See details»
WuXi XDC and AbTis Sign Memorandum of Understanding for …
SHANGHAI, China, and SEOUL, South Korea, July 8, 2022—WuXi XDC, a global leading CRDMO (Contract Research, Development and Manufacturing Organization) dedicated to end …See details»
AbTis - Overview, News & Similar companies | ZoomInfo.com
Jul 7, 2022 AbTis's headquarters are located at A-815 Suwon Venture Valley Ii 142-10 Saneop-ro 156 Beon-Gil Gwonseon-gu, Suwon-si, Gyeonggi-do, South Korea What is AbTis's official …See details»
AbTis - Products, Competitors, Financials, Employees, …
AbTis (앱티스) is a bio-venture company focused on drug development for anti-aging applications. Use the CB Insights Platform to explore AbTis's full profile. AbTis - Products, Competitors, …See details»
AbTis - Company Profile - Tracxn
Oct 23, 2024 AbTis ranks 19th among 273 active competitors. 17 of its competitors are funded while 37 have exited. Overall, AbTis and its competitors have raised over $304M in funding …See details»
AbTis
Site search. About Us: R&D: Business: IR/PR: Contact: AbTisSee details»
AbTis
The Company may share information provided by our visitors to abtis.co.kr with service providers we have retained to perform services on our behalf. These service providers are contractually …See details»
WuXi XDC and AbTis Sign Memorandum of Understanding for …
Jul 8, 2022 AbTis' advanced ADC technology enables partners to co-develop pipelines together in a real open innovation setting. For more information about AbTis, please visit: …See details»
AbTis Co., Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
SHANGHAI and SEOUL, South Korea, July 7, 2022 /PRNewswire/ -- WuXi XDC, a global leading CRDMO (Contract Research, Development and Manufacturing Organization) dedicated to end …See details»
AbTis Co., Ltd. - VentureRadar
Similar Companies: Independent - Carlos Pittol Unknown n/a Biotechnology analyst and consultant.. BAY GENOMICS LLC Unknown n/a Biotechnology consulting company.. BioM …See details»
WuXi XDC and AbTis Sign Memorandum of Understanding for …
Jul 8, 2022 SHANGHAI and SEOUL, South Korea, July 8, 2022 /PRNewswire/ -- WuXi XDC, a global leading CRDMO (Contract Research, Development and Manufacturing Organization) …See details»
ABCLICK Trademark of AbTis Co., Ltd.. Serial Number: 79264568 ...
May 12, 2020 TrademarkElite is the U.S. #1 Trademark Search and Registration Service :: ABCLICK is a trademark and brand of AbTis Co., Ltd., , KR. This trademark application was …See details»
WuXi XDC and AbTis Sign Memorandum of Understanding for
Jul 8, 2022 SHANGHAI and SEOUL, South Korea, July 8, 2022 /PRNewswire/ -- WuXi XDC, a global leading CRDMO (Contract Research, Development and Manufacturing Organization) …See details»
AbTis
A-815, Venture Valley2, Sanup-ro 156, 142-10 Kwonsun-gu, Suwon-si, Gyeonggi-do 16648. Republic of KoreaSee details»
AbTis
- Raised $13M in Series B Funding - MOU for ADC Development (Abclone,Y-biologics) - Claudin18.2 mAb L/I from GenScriptSee details»
AbTis Develops Next Generation ADC with iProgen Biotech in …
Jan 3, 2020 President Sang Jeon Chung of AbTis stated, “… the appointment of our company to be in charge of ‘Projects of International Co-development’ became the moment of global …See details»
AbTis
AbTis aims to develop ‘First-in Class’ and ‘Best-in Class’ ADC pipelines based on its own 3rd generation linker platform technology, AbClick®.See details»